An influenza vaccine that protects against death and serious complications from different strains of flu is a little closer to reality, Saint Louis University vaccine researchers have found.
"This is a significant first step in developing a universal vaccine to help protect against pandemic influenza," said Robert Belshe, M.D., director of the Saint Louis University Center for Vaccine Development.
Belshe, the lead researcher who studied a vaccine made with proteins from strains of influenza viruses A and B, presents his findings on April 27 at the National Foundation for Infectious Disease Conference for Vaccine Research in Baltimore.
"This is a significant first step in developing a universal vaccine to help protect against pandemic influenza," said Robert Belshe, M.D., director of the Saint Louis University Center for Vaccine Development.
Belshe, the lead researcher who studied a vaccine made with proteins from strains of influenza viruses A and B, presents his findings on April 27 at the National Foundation for Infectious Disease Conference for Vaccine Research in Baltimore.
